Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | CA2 | P00918 | 9/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 4/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11458719 | 0.91 | ALDH1A1 (0.52) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL28683257 | 0.91 | LMNA (0.52) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL28575196 | 0.90 | CA2 (0.48) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL11475343 | 0.89 | CA2 (0.55) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL11459440 | 0.89 | CA2 (0.55) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL11475280 | 0.87 | CA2 (0.53) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL15266210 | 0.87 | CA2 (0.53) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL15671076 | 0.87 | CA2 (0.48) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL11980515 | 0.86 | CA2 (0.61) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL11477827 | 0.86 | CA2 (0.52) | ALDH1A1CA2CYP3A4TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2397475-B1 | 4, 4' disubstituted 4H-cyclopentadithiophene and new methods for synthesising the same | IMEC (BE) | 2014-11-12 | — | — | EP | disclosed |
| US-8329923-B2 | 4, 4′ disubstituted 4H-cyclopentadithiophene and new methods for synthesizing the same | IMEC (BE) | 2012-12-11 | — | — | US | disclosed |
| US-8329923-B2 | 4, 4′ disubstituted 4H-cyclopentadithiophene and new methods for synthesizing the same | IMEC (BE) | 2012-12-11 | — | — | US | disclosed |
| US-20110313175-A1 | 4, 4' DISUBSTITUTED 4H-CYCLOPENTADITHIOPHENE AND NEW METHODS FOR SYNTHESISING THE SAME | UNIVERSITEIT HASSELT (BE) | 2011-12-22 | — | — | US | disclosed |
| US-20110313175-A1 | 4, 4' DISUBSTITUTED 4H-CYCLOPENTADITHIOPHENE AND NEW METHODS FOR SYNTHESISING THE SAME | UNIVERSITEIT HASSELT (BE) | 2011-12-22 | — | — | US | disclosed |
| EP-2397475-A1 | 4, 4' disubstituted 4H-cyclopentadithiophene and new methods for synthesising the same | IMEC (BE) | 2011-12-21 | — | — | EP | disclosed |
| US-7365235-B2 | Processes for producing branched compounds via condensation and hydrogenation | COGNIS DEUTSCHLAND GMBH & CO. KG (DE) | 2008-04-29 | — | — | US | disclosed |
| EP-1318972-B1 | METHOD FOR PRODUCING BRANCHED ALCOHOLS AND/OR HYDROCARBONS | COGNIS IP MAN GMBH (DE) | 2006-11-02 | — | — | EP | disclosed |
| US-20030181769-A1 | Method for producing branched alcohols and/or hydrocarbons | COGNIS IP MANAGEMENT GMBH (DE) | 2003-09-25 | — | — | US | disclosed |
| EP-1318972-A1 | METHOD FOR PRODUCING BRANCHED ALCOHOLS AND/OR HYDROCARBONS | Cognis Deutschland GmbH & Co. KG (DE) | 2003-06-18 | — | — | EP | disclosed |
| WO-2002024621-A1 | METHOD FOR PRODUCING BRANCHED ALCOHOLS AND/OR HYDROCARBONS | COGNIS DEUTSCHLAND GMBH & CO. KG (DE) | 2002-03-28 | — | — | WO | disclosed |
| US-4373008-A | Ambient hydrocurable coating compositions | ROHM AND HAAS COMPANY (US) | 1983-02-08 | — | — | US | disclosed |
| US-4299867-A | ACRYLIC POLYMER OF AN OXAZOLIDINE FUNCTIONAL MONOMER AND AN UNSATURATED ESTER | ROHM AND HAAS COMPANY (US) | 1981-11-10 | — | — | US | disclosed |
| EP-0034720-A2 | Hydrocurable compositions comprising substituted oxazolidine or oxazine polymer and poly acryloxy compound, and their use in coatings, impregnants and adhesives | ROHM AND HAAS COMPANY (US) | 1981-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313175-A1 | 4, 4' DISUBSTITUTED 4H-CYCLOPENTADITHIOPHENE AND NEW METHODS FOR SYNTHESISING THE SAME | DDT, NISCH, DBH | ALDH1A1 2561/4885CA2 113/4885CYP3A4 1027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.